Ed Torres - Profile and Investment Details

Investor Profile

Ed Torres is a Corporate Venture Capital based in Indianapolis, Indiana, United States with a diverse investment portfolio that includes companies such as Avid Radiopharmaceuticals, GlobeImmune, Sutro Biopharma, Cerulean Pharma, Numerate, Symic Biomedical, Intradigm Corporation, Protagonist Therapeutics, Conforma Therapeutics, Lysosomal Therapeutics, Kymera Therapeutics, Serenex, Aileron Therapeutics, Surface Oncology, Receptos, CGI Pharmaceuticals, Hydra BiosciencesNimbus Therapeutics, InnoCentive, FORMA Therapeutics, Cylene Pharmaceuticals, Aeglea BioTherapeutics, Cabrellis Pharmaceuticals, Nanostream Inc., MedManage Systems, Cavion, NexCura, Viamet Pharmaceuticals, Coherus Biosciences, Remon Medical Technologies, Bayhill Therapeutics, Viracta Therapeutics, Fluidigm, Trinity Biosystems, . Over time, Ed Torres has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ed Torres is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Alternative Medicine, Women Founded, Information Technology (IT), Biotechnology, Medical, Therapeutics, Pharmaceuticals, Business Intelligence may find it worthwhile to explore potential connections with Ed Torres, as their portfolio suggests a familiarity and interest in this area.

Understanding Ed Torres’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.